Clindamycin Phosphate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Clindamycin Phosphate
US Patents

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Clindamycin Phosphate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

34 API Suppliers, 19 USDMF, 12 CEP/COS, 6 JDMF, 1 EU WC, 1 KDMF, 13 NDC API, 17 Listed Suppliers, $ API Reference Price

34 API Suppliers
19 USDMF
12 CEP/COS
6 JDMF
1 EU WC
1 KDMF
13 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

169 FDF Dossiers, 133 FDA Orange Book, 10 Europe, 16 Canada, 1 South Africa, 9 Listed Dossiers

169 FDF Dossiers
133 FDA Orange Book
10 Europe
16 Canada
1 South Africa
9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML), INJECTABLE;INJECTION - EQ 150MG BASE/ML, SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - EQ 1% BASE, GEL;TOPICAL - EQ 1% BASE, GEL;TOPICAL - 5%;1.2%, GEL;TOPICAL - 5%;EQ 1% BASE, SUPPOSITORY;VAGINAL - 100MG, GEL;TOPICAL - EQ 1% BASE, CREAM;VAGINAL - EQ 2% BASE, AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 1.2%;0.025%

SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML)
INJECTABLE;INJECTION - EQ 150MG BASE/ML
SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
LOTION;TOPICAL - EQ 1% BASE
GEL;TOPICAL - EQ 1% BASE
GEL;TOPICAL - 5%;1.2%
GEL;TOPICAL - 5%;EQ 1% BASE
SUPPOSITORY;VAGINAL - 100MG
GEL;TOPICAL - EQ 1% BASE
CREAM;VAGINAL - EQ 2% BASE
AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TOPICAL - 1.2%;0.025%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 3 SPI Pharma, 5 DKSH, 1 Pharm-RX Chemical, 1 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 8 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 13 BASF, 1 BioSpectra, 1 Clariant, 6 Corel Pharma Chem, 2 Finar, 7 Gangwal Chemicals, 8 Kerry, 5 Lubrizol Life Science Health, 4 Microlex e.U, 1 Nanjing Bold Chemical, 2 Pluviaendo, 16 Roquette, 10 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

2 EUROAPI
2 Rochem International Inc
3 SPI Pharma
5 DKSH
1 Pharm-RX Chemical
1 Gangwal Healthcare
10 Nanjing Well Pharmaceutical
1 Pfanstiehl
8 Actylis
1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
13 BASF
1 BioSpectra
1 Clariant
6 Corel Pharma Chem
2 Finar
7 Gangwal Chemicals
8 Kerry
5 Lubrizol Life Science Health
4 Microlex e.U
1 Nanjing Bold Chemical
2 Pluviaendo
16 Roquette
10 Seppic
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries
1 Valens Pharmachem
1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

37 Topical, 24 Solubilizers, 23 Thickeners and Stabilizers, 23 Parenteral, 16 Film Formers & Plasticizers, 14 Emulsifying Agents, 13 Fillers, Diluents & Binders, 9 Coating Systems & Additives, 8 Surfactant & Foaming Agents, 8 Co-Processed Excipients, 7 Direct Compression, 7 Controlled & Modified Release, 6 Rheology Modifiers, 6 Lubricants & Glidants, 5 Taste Masking, 4 Granulation, 3 API Stability Enhancers, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin

37 Topical
24 Solubilizers
23 Thickeners and Stabilizers
23 Parenteral
16 Film Formers & Plasticizers
14 Emulsifying Agents
13 Fillers, Diluents & Binders
9 Coating Systems & Additives
8 Surfactant & Foaming Agents
8 Co-Processed Excipients
7 Direct Compression
7 Controlled & Modified Release
6 Rheology Modifiers
6 Lubricants & Glidants
5 Taste Masking
4 Granulation
3 API Stability Enhancers
2 Chewable & Orodispersible Aids
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 56 News #PharmaBuzz

1 Data Compilation #PharmaFlow
56 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 9 Regulatory FDF Prices

4 US Medicaid Prescriptions
9 Regulatory FDF Prices

MARKET PLACE

32 APIs, 4 FDF Dossiers

32 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

21 US Patents, 2 US Exclusivities

21 US Patents
2 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 2 Others

3 EDQM
1 USP
2 Others

$ API Ref.Price (USD/KG) : 137 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

21 All

01 19BAUSCH

02 1ORGANON LLC

03 1PADAGIS US

filter Patent Number Reset all filters

21 All

01 78288434

02 18663699

03 18895070

04 19078870

05 49504704

06 19561208

07 19789057

08 110137142

09 210220049

10 110624918

11 111129896

filter API Patent Reset all filters

21 All

01 21Blank

filter FDF Patent Reset all filters

21 All

01 17Y

02 4Blank

filter Expiration Date Reset all filters

21 All

01 12026-12-02

02 122029-06-03

03 72029-08-05

04 12036-09-22

Product Main Page

01

BAUSCH

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Immuno-Oncology 360

Not Confirmed

BAUSCH

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-05

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

US Patent Number : 8288434

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50819

Patent Use Code : U-818

Delist Requested :

Patent Use Description : TOPICAL TREATMENT OF A...

Patent Expiration Date : 2029-08-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BAUSCH

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Immuno-Oncology 360

Not Confirmed

BAUSCH

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-05

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

US Patent Number : 8288434

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50819

Patent Use Code : U-124

Delist Requested :

Patent Use Description : TREATMENT OF ACNE

Patent Expiration Date : 2029-08-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BAUSCH

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Immuno-Oncology 360

Not Confirmed

BAUSCH

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-05

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

US Patent Number : 8288434

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50819

Patent Use Code : U-134

Delist Requested :

Patent Use Description : TREATMENT OF ACNE VULG...

Patent Expiration Date : 2029-08-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BAUSCH

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Immuno-Oncology 360

Not Confirmed

BAUSCH

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-06-03

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

US Patent Number : 9561208

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50819

Patent Use Code : U-916

Delist Requested :

Patent Use Description : TOPICAL TREATMENT OF A...

Patent Expiration Date : 2029-06-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

BAUSCH

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Immuno-Oncology 360

Not Confirmed

BAUSCH

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-06-03

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

US Patent Number : 10220049

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50819

Patent Use Code : U-916

Delist Requested :

Patent Use Description : TOPICAL TREATMENT OF A...

Patent Expiration Date : 2029-06-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

BAUSCH

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Immuno-Oncology 360

Not Confirmed

BAUSCH

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-06-03

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

US Patent Number : 9504704

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50819

Patent Use Code : U-134

Delist Requested :

Patent Use Description : TREATMENT OF ACNE VULG...

Patent Expiration Date : 2029-06-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

BAUSCH

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Immuno-Oncology 360

Not Confirmed

BAUSCH

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-06-03

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

US Patent Number : 9504704

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50819

Patent Use Code : U-818

Delist Requested :

Patent Use Description : TOPICAL TREATMENT OF A...

Patent Expiration Date : 2029-06-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

BAUSCH

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Immuno-Oncology 360

Not Confirmed

BAUSCH

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-06-03

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

US Patent Number : 9504704

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50819

Patent Use Code : U-916

Delist Requested :

Patent Use Description : TOPICAL TREATMENT OF A...

Patent Expiration Date : 2029-06-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

BAUSCH

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Immuno-Oncology 360

Not Confirmed

BAUSCH

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-05

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

US Patent Number : 8288434

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50819

Patent Use Code : U-124

Delist Requested :

Patent Use Description : TREATMENT OF ACNE

Patent Expiration Date : 2029-08-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

BAUSCH

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

Immuno-Oncology 360

Not Confirmed

BAUSCH

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-05

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE

US Patent Number : 8288434

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50819

Patent Use Code : U-1033

Delist Requested :

Patent Use Description : TOPICAL TREATMENT OF A...

Patent Expiration Date : 2029-08-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!